在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human NAD (P)H Dehydrogenase, Quinone 1 (NQO1)ELISA Kit

  • 中文名稱:
    人醌NADH脫氫酶1(NQO1)酶聯免疫試劑盒
  • 貨號:
    CSB-E14923h
  • 規格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人醌NADH脫氫酶1(NQO1)酶聯免疫試劑盒(CSB-E14923h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿、細胞裂解物樣本中的NQO1含量。NQO1是一種具有重要意義的靶點。它在細胞代謝和抗氧化等方面發揮作用,與多種疾病發生發展相關。研究機制上,主要圍繞其酶活性、底物作用等展開,探索它在疾病進程中的角色及影響,為相關疾病的治療提供潛在靶點和思路。試劑盒檢測范圍為39 pg/mL-2500 pg/mL,支持科研人員開展細胞氧化還原調控機制、疾病相關生物標志物篩選、藥物干預效果評估等研究;適用于分子生物學實驗室常規檢測需求本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    Azoreductase ELISA Kit; Cytochrome b 5 reductase ELISA Kit; DHQU ELISA Kit; DIA 4 ELISA Kit; DIA4 ELISA Kit; Diaphorase (NADH/NADPH) (cytochrome b 5 reductase) ELISA Kit; Diaphorase (NADH/NADPH) ELISA Kit; Diaphorase 4 ELISA Kit; Dioxin inducible 1 ELISA Kit; DT diaphorase ELISA Kit; DT-diaphorase ELISA Kit; DTD ELISA Kit; Menadione reductase ELISA Kit; NAD(P)H dehydrogenase [quinone] 1 ELISA Kit; NAD(P)H dehydrogenase quinone 1 ELISA Kit; NAD(P)H menadione oxidoreductase 1 dioxin inducible ELISA Kit; NAD(P)H quinone dehydrogenase 1 ELISA Kit; NAD(P)H: menadione oxidoreductase 1 dioxin inducible 1 ELISA Kit; NAD(P)H:menadione oxidoreductase 1 ELISA Kit; NAD(P)H:Quinone acceptor oxidoreductase type 1 ELISA Kit; NAD(P)H:quinone oxidoreductase 1 ELISA Kit; NAD(P)H:quinone oxireductase ELISA Kit; NMOR 1 ELISA Kit; NMOR I ELISA Kit; NMOR1 ELISA Kit; NMORI ELISA Kit; NQO 1 ELISA Kit; NQO1 ELISA Kit; NQO1_HUMAN ELISA Kit; Phylloquinone reductase ELISA Kit; QR 1 ELISA Kit; QR1 ELISA Kit; Quinone reductase 1 ELISA Kit
  • 縮寫:
    NQO1
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates, cell lysates
  • 檢測范圍:
    39 pg/mL-2500 pg/mL
  • 靈敏度:
    9.75 pg/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Metabolism
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human NQO1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    SampleSerum(n=4)
    1:1Average %97
    Range %89-101
    1:2Average %89
    Range %91-94
    1:4Average %90
    Range %82-94
    1:8Average %94
    Range %84-99
  • 回收率:
    The recovery of human NQO1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 9284-95
    EDTA plasma (n=4)9991-103
  • 標準曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    pg/mlOD1OD2AverageCorrected
    25002.633 2.551 2.592 2.450
    12502.093 1.976 2.035 1.893
    6251.398 1.345 1.372 1.230
    3120.733 0.747 0.740 0.598
    1560.456 0.494 0.475 0.333
    780.278 0.292 0.285 0.143
    390.221 0.217 0.219 0.077
    00.144 0.140 0.142
  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

靶點詳情

  • 功能:
    The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.
  • 基因功能參考文獻:
    1. functional perturbation analyses at cancer-associated P187 and K240 sites of the multifunctional NADP(H):quinone oxidoreductase 1 PMID: 30009918
    2. NQO1 is a FAD-dependent, two-domain multifunctional stress protein acting as a Phase II enzyme, activating cancer pro-drugs and stabilizing p53 and p73a oncosuppressors.tructural protein:protein interaction studies reveal that the cancer-associated polymorphism does not abolish the interaction with p73alpha, indicating that oncosuppressor destabilization largely mirrors the low intracellular stability of p.P187S. PMID: 28291250
    3. Inflammation, oxidative stress, and higher expression levels of Nrf2 and NQO1 proteins in the airways of women chronically exposed to biomass fuel smoke. PMID: 29363060
    4. NQO1 directly binds to the oxygen-dependent domain of HIF-1alpha and inhibits the proteasome-mediated degradation of HIF-1alpha by preventing PHDs from interacting with HIF-1alpha. PMID: 27966538
    5. Our genetic susceptibility study suggests that the NQO1 wild homozygous is likely to be the susceptible genotype. It means that low dose exposure to benzene (concentration under 0.6 mg/m3) can still cause health hazards to workers, and those workers with NQO1 wild homozygous genotypes were more susceptible than others. PMID: 29116991
    6. Although the NQO1 rs1800566 variant may not have an effect on risk of pre-eclampsia (PE) in Chinese Han women, further studies of other loci are necessary to clarify the exact role of NQO1 in the pathogenesis of PE. PMID: 29153688
    7. results obtained here support a previously unrecognized molecular link between polycystic ovary syndrome and endometrial cancer involving NQO1. PMID: 28748640
    8. In human colonic epithelial cells, significant upregulation of NAD(P)H dehydrogenase [quinone] 1 (up to threefold) and thioredoxin reductase 1 (up to twofold) by 10muM sulforaphane (from broccoli), 5muM carnosol (rosemary), and 20muM cinnamaldehyde (cinnamon) was observed. PMID: 28688915
    9. Hydrogen sulfide attenuates vascular smooth muscle cell calcification in vitro via the KEAP1-NRF2 redox sensing/stress response system by enhancing NQO1 expression. PMID: 28865326
    10. the NRF2 target NAD(P)H:quinone oxidoreductase 1 (NQO1) was investigated as a readout parameter for NRF2 activity in monocytes of chronic kidney disease patients (n = 63) compared to those of healthy controls. PMID: 28785379
    11. NQO1 is a potential drug target for host directed therapy for tuberculosis. PMID: 27297123
    12. These results indicate that dual-negative expression of Nrf2 and NQO1 is predictive of a better prognosis in NSCLC patients. PMID: 28501854
    13. the NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism combination with smoking significantly confer susceptibility to BC. [META-ANALYSIS] PMID: 28589969
    14. Docosahexaenoic acid (DHA) activates Nrf2, possibly through modification of critical Keap1 cysteine 288 residue and PKCdelta-mediated phosphorylation of Nrf2, leading to upregulation of HO-1 and NQO1 expression. PMID: 28604588
    15. the upregulation of Cav1 contributed to the DHA-mediated p53 activation and the downregulation of the redox enzyme, NAD(P)H:quinone oxidoreductase 1 (NQO1), which have been reported to contribute to the activation of the cell death pathway. PMID: 28498397
    16. NQO1 may act as a redox-dependent switch where the protein responds to the NAD(P)+/NAD(P)H redox environment by altering its structure promoting the binding or dissociation of NQO1 with target macromolecules PMID: 29298345
    17. Taken together, we proposed that NQO1 could potentiate NSCLC cell proliferation by enhancing cellular glycometabolism, and HKII is a key mediator of this mechanism. PMID: 29291405
    18. The higher incidence of NQO1 mutants among bronchopulmonary dysplasia (BPD) neonates as well as the presence of the mutant allele in all neonates with <= 1,000 g who developed BPD provided the first evidence for a possible pathogenetic role of the C(609)T polymorphism in BPD susceptibility due to the reduction or loss of NQO1 enzymatic activity. PMID: 26683602
    19. Activity of the enzyme NQO1 does not appear to be developmentally regulated, with levels of hepatic activity as high in neonates and children as they are in adults. Obesity may increase hepatic NQO1 activity in children. PMID: 26856346
    20. Novel RNA-binding activity of NQO1 promotes SERPINA1 mRNA translation. PMID: 27515817
    21. NQO1 overexpression correlated to tumor size, venous infiltration and late pTNM stage of hepatocellular carcinoma. NQO1 overexpression was also related to low disease-free survival and 5-year survival rates. PMID: 28964792
    22. Results from reverse transcription polymerase chain reaction and promoter assays reveal that HX-1171 increased the expression of NQO1 and HMOX1, encoding antioxidant-related enzymes, in A549 human lung epithelial cells. PMID: 28300285
    23. Results show that H80R causes a population shift in the conformational ensemble of apo-P187S, remodelling the structure and dynamics of the FAD-binding site and reducing the energetic penalization arising from the equilibrium between apo- and holo-states. PMID: 28771686
    24. The C609T polymorphism within NQO1 is independently associated with CAD in women, but no association was observed in whole study population or in men. PMID: 26690082
    25. This study suggests that HNC samples should be screened for NQO1 expression to identify patients that will likely benefit from combined therapy with beta-lap and IR. PMID: 27196777
    26. The results indicate that NQO1*2 genotype may increase susceptibility to DN in north Indian subjects with T2DM. PMID: 27078674
    27. Thus, our findings indicated that NQO1 could stabilize Herp protein expression via indirect regulation of synoviolin. PMID: 27084451
    28. NQO1 and GCLC were both functionally sufficient to autonomously confer a tamoxifen-resistant metabolic phenotype, characterized by i) increased mitochondrial biogenesis, ii) increased ATP production and iii) reduced glutathione levels. PMID: 28411284
    29. NQO1 induces hepatocellular carcinoma cell apoptosis and proliferation inhibition through the AMPK/PGC-1alpha pathway. PMID: 28191864
    30. the expression of NRF2, KEAP1, NQO-1 and HO-1 are increased significantly in advanced laryngeal squamous cell carcinoma, compared with the adjacent normal mucosa. Remarkable relevance exists between high expression of KEAP1, NQO-1, HO-1 and nuclear NRF2. their expression levels were independent of age, tumor stage (clinical stage III and IV), tumor size and lymph node metastasis. PMID: 27840932
    31. (i) melatonin counteracted UVR-induced alterations in the ATP synthesis and reduced free radical formation; (ii) melatonin induced the translocation of Nrf2 transcription factor from the cytosol into the nucleus resulting in, (iii) melatonin enhanced gene expression of phase-2 antioxidative enzymes including gamma-glutamylcysteine synthetase (gamma-GCS), heme oxygenase-1 (HO-1), and NADPH: quinone dehydrogenase-1 (NQO1... PMID: 27117941
    32. Coptisine exerted its antioxidant activity against AAPH-induced toxicity involving in activating Akt and JNK/Nrf2/NQO1 pathway. PMID: 27903425
    33. These results do not support the view that the C609T polymorphism has a role in the pathogenesis of Myelodysplastic Syndrome. PMID: 27453274
    34. significant structural and functional changes incurred by NQO1 antioxidant protein as a result of alteration in its nucleotide, are reported. PMID: 27349566
    35. Study provides a comprehensive picture of the structural and dynamic consequences of NQO1 polymorphisms, linking changes in protein dynamics with impaired NQO1 function and FAD binding, particularly for p.P187S, leading to increased cancer susceptibility. PMID: 26838129
    36. Polymorphism of the NQO1 Gene is associated with Breast Cancer. PMID: 27039751
    37. patients who carry the wild type genotype or only one polymorphism for either NQO1 or GSTP1 gene have possibly a better clinical outcome after the natalizumab therapy. PMID: 27993870
    38. The association of colorectal adenomas with the rs6983267 variant at 8q24 was considered as 'highly credible', the 'less credible' associations were identified with a further four variants of four independent genes: MTHFR c.677C>T p.A222V(rs1801133), TP53 c.215C>G p.R72P (rs1042522), NQO1 c.559C>T p.P187S (rs1800566), and NAT1 alleles imputed as fast acetylator genotypes. [meta-analysis] PMID: 26451011
    39. Results show that NQO1 is up-regulated in non-small cell lung neoplasm which correlates with poor survival. PMID: 26553038
    40. Meta-analysis. our results showed that NQO1 C609T polymorphism increases the risk of Alzheimer disease in Chinese populations. PMID: 25562627
    41. The present study revealed that NQO1 CT, TT and CT+TT genotypes may be associated with clinical outcome and risk of developing NSCLC in the Indian population. PMID: 26625776
    42. Flavin reductase and calreticulin play key roles in the development of pemetrexed-associated resistance in lung adenocarcinoma cells. PMID: 26452990
    43. NQO1 was significantly increased in all of the diseased livers including peri-hepatocellular carcinoma tissues. PMID: 26459724
    44. NQO1 single nucleotide polymorphism rs1800566 involved in the ornithine decarboxylase pathway can be a genetic susceptibility factor for gastric cancer. PMID: 25079701
    45. NQO1 overexpression was a main determinant for a potential chemotherapy resistance or an increased sensitivity to quinone-bearing compounds. PMID: 26687450
    46. mercury increases oxidative stress (increased HO1 and NQO1 mRNA levels) and alters the cytoskeleton in the human endometrial Ishikawa cell line and to a lesser extent, in the "less-differentiated" human endometrial Hec-1b cells PMID: 26600472
    47. NQO1 gene polymorphisms influence stable warfarin doses in Korean patients PMID: 26257249
    48. The present results demonstrate that exacerbated cisplatin-induced nephrotoxicity under the NQO1-knockout condition was accompanied by the reduced expression of MRN complex proteins, ATM, PARP1, and Sirt1. PMID: 26723870
    49. Its genotype in cervical cell samples may be associated with more severe precancerous lesions of the cervix in a Japanese population. PMID: 25697264
    50. NQO1 Stabilizes p53 in Response to Oncogene-Induced Senescence. PMID: 26078718

    顯示更多

    收起更多

  • 亞細胞定位:
    Cytoplasm.
  • 蛋白家族:
    NAD(P)H dehydrogenase (quinone) family
  • 數據庫鏈接:

    HGNC: 2874

    OMIM: 125860

    KEGG: hsa:1728

    STRING: 9606.ENSP00000319788

    UniGene: Hs.406515



主站蜘蛛池模板: 夜夜高潮夜夜爽高清视频| 人妻无码中字在线a| 欧美黑人又粗又大的性格特点| 欧美自拍另类欧美综合图片区| 99精品国产免费观看视频| 日本强伦姧人妻一区二区| 无码专区―va亚洲v专区在线| 在线观看国产精品av| 国产亚洲精品字幕在线观看| 蜜芽久久人人超碰爱香蕉| 无码尹人久久相蕉无码| 一边做一边喷17p亚洲乱妇50p| 中日产幕无线码一区| 18禁免费无码无遮挡不卡网站| 手机在线看片| 日本一卡2卡三卡4卡免费网站| 国产成人啪精品视频网站午夜| 日本熟妇浓毛hdsex| 亚洲v国产v欧美v久久久久久| 七七久久成人影院网站| 亚洲精品综合一区二区| 国产av无码国产av毛片| 国产精品一卡二卡三卡| 精品国产乱码久久久久久乱码| 国产精品久久久久无码av1| 在线观看特色大片免费网站| 亚洲色大成网站www永久网站| 久草热8精品视频在线观看| 亚洲日韩色欲色欲com| 亚洲精品国产suv| 日本强伦片中文字幕免费看| 国产国产成人久久精品| 国产亚洲精品久久久久丝瓜| 国产精品嫩草影院av| 在线毛片片免费观看| 精品国产成人网站一区在线| 唐人社导航福利精品| 国产一卡三卡四卡无卡精品| 无码人妻久久一区二区三区app| 熟女人妻水多爽中文字幕| 欧美 国产日韩 综合在线|